Helix BioMedix, Inc.
OTC: HXBM0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Robin L. Carmichael
- Employees
- 8
- Headquarters
- Bothell, United States
- IPO year
- 1999
- Market cap
- $402.2K
- Website
- https://www.helixbiomedix.com
Loading HXBM…
Loading profile data…Frequently asked questions about HXBM
What does Helix BioMedix, Inc. (HXBM) do?
Helix BioMedix, Inc. is a U.S.-based enterprise specializing in skin health, focusing on advanced dermatology and consumer-oriented product lines. The company's primary activity involves creating and bringing to market bioactive peptides. These compounds are engineered to combat infections, fungal growths, and inflammation, serving to treat vari...
Where does HXBM trade?
Helix BioMedix, Inc. (HXBM) trades on the Other OTC.
What sector is HXBM in?
Helix BioMedix, Inc. (HXBM) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Helix BioMedix, Inc.?
Robin L. Carmichael is the chief executive officer of Helix BioMedix, Inc. (HXBM).
Where is Helix BioMedix, Inc. headquartered?
Helix BioMedix, Inc. is headquartered in United States.
Does HXBM pay a dividend?
Helix BioMedix, Inc. (HXBM) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did HXBM go public?
Helix BioMedix, Inc. (HXBM) completed its initial public offering in 1999.